565 related articles for article (PubMed ID: 26176710)
1. The impact of non-alcoholic fatty liver disease on incident type 2 diabetes mellitus in non-overweight individuals.
Fukuda T; Hamaguchi M; Kojima T; Hashimoto Y; Ohbora A; Kato T; Nakamura N; Fukui M
Liver Int; 2016 Feb; 36(2):275-83. PubMed ID: 26176710
[TBL] [Abstract][Full Text] [Related]
2. Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus.
Li WD; Fu KF; Li GM; Lian YS; Ren AM; Chen YJ; Xia JR
World J Gastroenterol; 2015 Aug; 21(32):9607-13. PubMed ID: 26327768
[TBL] [Abstract][Full Text] [Related]
3. Transient remission of nonalcoholic fatty liver disease decreases the risk of incident type 2 diabetes mellitus in Japanese men.
Fukuda T; Hamaguchi M; Kojima T; Mitsuhashi K; Hashimoto Y; Ohbora A; Kato T; Nakamura N; Fukui M
Eur J Gastroenterol Hepatol; 2016 Dec; 28(12):1443-1449. PubMed ID: 27603300
[TBL] [Abstract][Full Text] [Related]
4. Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD).
Cuthbertson DJ; Koskinen J; Brown E; Magnussen CG; Hutri-Kähönen N; Sabin M; Tossavainen P; Jokinen E; Laitinen T; Viikari J; Raitakari OT; Juonala M
Ann Med; 2021 Dec; 53(1):1256-1264. PubMed ID: 34309471
[TBL] [Abstract][Full Text] [Related]
5. Independent Association Between Improvement of Nonalcoholic Fatty Liver Disease and Reduced Incidence of Type 2 Diabetes.
Yamazaki H; Tsuboya T; Tsuji K; Dohke M; Maguchi H
Diabetes Care; 2015 Sep; 38(9):1673-9. PubMed ID: 26156527
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound-Diagnosed Nonalcoholic Fatty Liver Disease Independently Predicts a Higher Risk of Developing Diabetes Mellitus in Nonoverweight Individuals.
Wang L
Acad Radiol; 2019 Jul; 26(7):863-868. PubMed ID: 30254005
[TBL] [Abstract][Full Text] [Related]
7. Association between the lean nonalcoholic fatty liver disease and risk of incident type 2 diabetes in a healthy population of Northwest China: a retrospective cohort study with a 2-year follow-up period.
Li N; Xang W; Wu S; Li D; Chang M; Xie C; Zhang MY; Tan H
Front Endocrinol (Lausanne); 2023; 14():1173757. PubMed ID: 37435491
[TBL] [Abstract][Full Text] [Related]
8. The persistence of fatty liver has a differential impact on the development of diabetes: The Kangbuk Samsung Health Study.
Bae JC; Han JM; Cho JH; Kwon H; Park SE; Park CY; Lee WY; Oh KW; Kwon S; Park SW; Rhee EJ
Diabetes Res Clin Pract; 2018 Jan; 135():1-6. PubMed ID: 29111276
[TBL] [Abstract][Full Text] [Related]
9. Light-to-Moderate Alcohol Consumption Is Associated With Increased Risk of Type 2 Diabetes in Individuals With Nonalcoholic Fatty Liver Disease: A Nine-Year Cohort Study.
Xu L; Xie J; Chen S; Chen Y; Yang H; Miao M; Zhu Z; Li Y; Yu C; Xu C
Am J Gastroenterol; 2020 Jun; 115(6):876-884. PubMed ID: 32282335
[TBL] [Abstract][Full Text] [Related]
10. Impact of hypothyroidism on the development of non-alcoholic fatty liver disease: A 4-year retrospective cohort study.
Lee KW; Bang KB; Rhee EJ; Kwon HJ; Lee MY; Cho YK
Clin Mol Hepatol; 2015 Dec; 21(4):372-8. PubMed ID: 26770926
[TBL] [Abstract][Full Text] [Related]
11. Is HOMA-IR a potential screening test for non-alcoholic fatty liver disease in adults with type 2 diabetes?
Gutierrez-Buey G; Núñez-Córdoba JM; Llavero-Valero M; Gargallo J; Salvador J; Escalada J
Eur J Intern Med; 2017 Jun; 41():74-78. PubMed ID: 28283346
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus infection and risk of non-alcoholic fatty liver disease: A population-based cohort study.
Zhu L; Jiang J; Zhai X; Baecker A; Peng H; Qian J; Zhou M; Song C; Zhou Y; Xu J; Liu H; Hang D; Hu Z; Shen H; Zhang ZF; Zhu F
Liver Int; 2019 Jan; 39(1):70-80. PubMed ID: 30025200
[TBL] [Abstract][Full Text] [Related]
13. Synergistic effect of non-alcoholic fatty liver disease and history of gestational diabetes to increase risk of type 2 diabetes.
Cho Y; Chang Y; Ryu S; Wild SH; Byrne CD
Eur J Epidemiol; 2023 Aug; 38(8):901-911. PubMed ID: 37253998
[TBL] [Abstract][Full Text] [Related]
14. Association of non-alcoholic fatty liver disease with total testosterone in non-overweight/obese men with type 2 diabetes mellitus.
Yang LJ; Zhou JZ; Zheng YF; Hu X; He ZY; Du LJ; Gu X; Huang XY; Li J; Li YQ; Pan LY; Zhang XX; Gu XJ
J Endocrinol Invest; 2023 Aug; 46(8):1565-1572. PubMed ID: 36725809
[TBL] [Abstract][Full Text] [Related]
15. Non-alcoholic fatty liver disease predicts type 2 diabetes mellitus, but not prediabetes, in Xi'an, China: a five-year cohort study.
Ming J; Xu S; Gao B; Liu G; Ji Y; Yang F; Jia Y; Fang Y; Ji Q
Liver Int; 2015 Nov; 35(11):2401-7. PubMed ID: 25879672
[TBL] [Abstract][Full Text] [Related]
16. Risk for the development of non-alcoholic fatty liver disease: A prospective study.
Wang J; Ma L; Chen S; Xu L; Miao M; Yu C; Li Y; Xu C
J Gastroenterol Hepatol; 2018 Aug; 33(8):1518-1523. PubMed ID: 29381226
[TBL] [Abstract][Full Text] [Related]
17. Nonoverweight nonalcoholic fatty liver disease and incident cardiovascular disease: A post hoc analysis of a cohort study.
Yoshitaka H; Hamaguchi M; Kojima T; Fukuda T; Ohbora A; Fukui M
Medicine (Baltimore); 2017 May; 96(18):e6712. PubMed ID: 28471965
[TBL] [Abstract][Full Text] [Related]
18. Combined influence of nonalcoholic fatty liver and body size phenotypes on diabetes risk.
Du T; Yu X; Yuan G; Zhang J; Sun X
Cardiovasc Diabetol; 2015 Oct; 14():144. PubMed ID: 26511621
[TBL] [Abstract][Full Text] [Related]
19. Bidirectional association between nonalcoholic fatty liver disease and type 2 diabetes in Chinese population: Evidence from the Dongfeng-Tongji cohort study.
Li Y; Wang J; Tang Y; Han X; Liu B; Hu H; Li X; Yang K; Yuan J; Miao X; Yao P; Wei S; Wang Y; Liang Y; Zhang X; Guo H; Pan A; Yang H; Hu FB; Wu T; He M
PLoS One; 2017; 12(3):e0174291. PubMed ID: 28350839
[TBL] [Abstract][Full Text] [Related]
20. Metabolically healthy obesity is associated with an increased risk of diabetes independently of nonalcoholic fatty liver disease.
Chang Y; Jung HS; Yun KE; Cho J; Ahn J; Chung EC; Shin H; Ryu S
Obesity (Silver Spring); 2016 Sep; 24(9):1996-2003. PubMed ID: 27474900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
